13262
Phase III clinical trials with peginesatide , a pegylated synthetic peptide - based ESA without any homology to erythropoietin raised safety concerns in non - dialysis CKD patients but not in dialysis patients .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None